{
  "drug_name": "lactobacillus",
  "nbk_id": "NBK618380",
  "url": "https://www.ncbi.nlm.nih.gov/books/NBK618380/",
  "scraped_at": "2026-01-11T18:47:23",
  "sections": {
    "indications": "Understanding the prevalence, distribution, and biological mechanisms of obesity is vital for shaping effective public health measures and clinical care strategies. The recent National Health and Nutrition Examination Survey (NHANES) data from 2021 to 2023 indicate that obesity affects 40.3% of adults in the United States (US), with the highest prevalence among middle-aged adults (eg, 40–59 years), marked by persistent demographic and geographic disparities. Severe obesity continues to rise, now impacting 9.4% of adults, with notable differences in sex and substantial associated healthcare costs. Geographic patterns reveal an 18.7 percentage point difference between the highest and lowest state rates, driven by socioeconomic, environmental, and cultural factors. Disparities across racial, ethnic, and educational groups further underscore the role of social determinants of health in obesity prevalence.\n\nBeyond epidemiology, advances in understanding the pathophysiology of obesity underscore its classification as a complex, chronic disease characterized by dysregulated neuroendocrine pathways, adaptive thermogenesis, and environmental interactions. Mechanisms, such as the set point and settling point models, alterations in the gut microbiome, epigenetic changes, and exposure to endocrine-disrupting chemicals, provide insight into disease persistence and treatment challenges. This knowledge forms the foundation for targeted, evidence-based prevention and management strategies that address both biological and social drivers of obesity.",
    "mechanism": "Recognizing obesity as a chronic disease fundamentally shifts the clinical approach from viewing weight as a lifestyle choice to defining it as a complex medical condition involving multiple interconnected biological systems. This pathophysiological framework provides the scientific foundation for evidence-based treatment approaches and helps explain the challenges inherent in obesity management.\n\nNeuroendocrine Weight Regulation Mechanisms\n\nComplex neural and hormonal networks regulate energy balance through feedback mechanisms that more strongly defend against weight loss than weight gain. Understanding these mechanisms provides insight into why obesity develops and persists despite individual efforts to control weight. Obesity represents a complex, chronic disease characterized by the dysregulation of multiple interconnected physiological systems that govern energy homeostasis. The central nervous system, particularly the hypothalamus, is the primary integration center for signals regulating food intake, energy expenditure, and maintaining body weight.\n[4]\nSee\nImage.\nNeuronal Regulation of Appetite Via Hypothalamic Circuits. Please refer to the StatPearls companion resource, \"\nObesity and SetPoint Theory\n,\" for further information.\n\nHypothalamic control networks\n\nThe hypothalamus's arcuate nucleus contains 2 functionally opposing neuronal populations that respond to circulating hormonal and nutrient signals (see\nTable 4\n). For further information, please refer to the StatPearls companion resource, \"\nPathophysiology of Obesity\n.\"\n\nAnorexigenic (appetite-suppressing) pathway\n\nThe anorexigenic, or appetite-suppressing, pathway involves proopiomelanocortin neurons, which produce the hormone proopiomelanocortin. This precursor is cleaved into α-melanocyte-stimulating hormone (α-MSH). When α-MSH binds to melanocortin-4 receptors (MC4R) in downstream brain regions, it activates anorexigenic signaling pathways. These pathways lead to decreased food intake, increased energy expenditure, and enhanced thermogenesis, thereby contributing to maintaining energy balance and regulating weight.\n\nOrexigenic (appetite-suppressing) pathway\n\nConversely, the orexigenic, or appetite-stimulating, pathway is mediated by neurons producing neuropeptide Y (NPY) and agouti-related peptide (AgRP). AgRP is an antagonist to MC4R signaling, while NPY actively promotes feeding behavior. This pathway increases food intake, reduces energy expenditure, and decreases thermogenesis, promoting energy storage and weight gain.\n\nTable\nTable 4. Major Weight-Regulating Hormones and Their Functions.\n\nAdaptive Thermogenesis and Metabolic Adaptation\n\nBiological mechanisms that defend against weight loss represent the primary challenge in long-term obesity management, explaining why sustainable weight maintenance requires ongoing medical intervention rather than short-term lifestyle changes. Adaptive thermogenesis is one of the most significant biological barriers to achieving and maintaining long-term weight management success. This phenomenon involves coordinated reductions in energy expenditure that exceed what would be predicted based solely on changes in body mass and composition.\n[5]\n\nMolecular mechanisms of adaptive thermogenesis\n\nAdaptive thermogenesis encompasses multiple coordinated physiological responses that collectively defend against energy deficit. The primary mechanism involves uncoupling protein 1 in brown adipose tissue, dissipating the proton gradient across mitochondrial membranes to produce heat instead of adenosine triphosphate.\n[6]\n\nQuantitative assessment of metabolic adaptation\n\nA systematic analysis of the results from controlled studies reveals that adaptive thermogenesis is a common feature in most weight loss interventions. Study results also show that an overcompensating mechanism in response to weight loss can trigger a 20% to 25% reduction in total energy expenditure (10%–15% beyond expected body composition changes).\n[7]\nIndividual variation in adaptive thermogenesis is dramatic, with recent study results showing early adaptive thermogenesis within the first week of caloric restriction averaging -178 ± 137 kcal/day, suggesting rapid physiological responses to an energy deficit that may predict the magnitude of longer-term adaptation.\n[8]\n\nPersistence and clinical implications\n\nThe persistence of metabolic adaptation varies significantly depending on the type of intervention, the magnitude of weight loss, and individual factors. The famous \"Biggest Loser\" study documented persistent adaptation (-500 kcal/day) at 6-year follow-up, while patients who have undergone bariatric surgery typically demonstrate adaptation resolution after 6 to 24 months.\n[9]\nClinical management implications include recognizing that many patients exhibit metabolic adaptations, necessitating individualized treatment approaches rather than uniform protocols. Understanding adaptation helps explain weight loss plateaus, the need for progressive caloric restriction, and challenges with long-term weight maintenance.\n[10]\n\nSet Point Theory and Settling Point Models\n\nTheoretical frameworks explaining weight regulation help clinicians understand the biological basis for weight regain and inform realistic treatment expectations. These models provide a scientific foundation for developing long-term obesity management strategies.\n\nTraditional set point theory\n\nThe set point theory proposes that body weight is regulated around a predetermined \"set point\" through homeostatic mechanisms that resist deviations from this weight. Supporting evidence includes animal studies demonstrating weight return to baseline levels after forced feeding or caloric restriction, and twin studies showing similar body weights among identical twins raised in different environments.\n[11]\n\nEmerging settling point models\n\nContemporary evidence favors \"settling point\" models over rigid set point theory. The settling point concept suggests that body weight reaches equilibrium based on the interaction between biological predisposition and environmental factors, without requiring active defense of a specific weight. This model comprehensively explains population-level increases in obesity and individual success stories from weight maintenance registries.\n[12]\n\nEmerging Factors in Obesity Pathogenesis\n\nContemporary research supports the concept that additional biological mechanisms contribute to the development and maintenance of obesity beyond traditional energy balance models. These emerging factors offer new insights into the pathogenesis of obesity and potential therapeutic targets.\n\nGut microbiome alterations\n\nThe gut microbiome has emerged as a critical focus in obesity research, supported by growing evidence of its influence on energy regulation, inflammatory processes, and overall metabolic health. Individuals with obesity often exhibit compositional shifts in their gut microbiota, frequently characterized by a higher Firmicutes-to-Bacteroidetes (F/B) ratio, although significant variability exists across studies. Several bacterial alterations consistently appear in the gut microbiome of individuals with obesity. Levels of\nAkkermansia muciniphila\n, a species that supports metabolic health and promotes energy expenditure, are commonly depleted;\nFaecalibacterium prausnitzii\n, a key butyrate producer contributing to intestinal health, is also often reduced. Conversely, populations of\nProteobacteria\nand\nFusobacteria\nfrequently increase, correlating with heightened inflammation and impaired metabolic function. Overall microbial diversity tends to decline, as reflected by lower Shannon diversity indices, which may diminish the gut's resilience and functional capacity.\n[13]\n\nThe gut microbiome composition exhibits distinct alterations in obesity, with the most widely studied being an elevated F/B ratio compared to lean individuals. This shift reflects changes in the 2 dominant bacterial phyla in the human gut, where Firmicutes, including genera such as\nLactobacillus, Clostridium\n, and\nEnterococcus,\nbecome proportionally more abundant while Bacteroidetes, including\nBacteroides\nand\nPrevotella,\ndecrease. The proposed mechanism involves Firmicutes' enhanced capacity for energy harvest from dietary polysaccharides through increased expression of genes encoding carbohydrate-active enzymes, potentially contributing to weight gain by extracting additional calories from the same food intake.\n\nHowever, this paradigm has faced scrutiny due to substantial between-study variability, with some investigations reporting no significant F/B ratio differences or even contradictory findings. Methodological factors, including DNA extraction protocols, sequencing platforms, geographical populations studied, and confounding variables (eg, diet, medications, and comorbidities), likely contribute to this heterogeneity, emphasizing that obesity-associated dysbiosis extends beyond simple ratio measurements to encompass broader taxonomic and functional diversity changes.\n\nEpigenetic mechanisms\n\nDNA methylation patterns show consistent associations with obesity across multiple populations and tissue types. Tissue-specific epigenetic patterns reveal multiple genes exhibiting correlated methylation-expression changes that affect key metabolic pathways, including lipid metabolism, inflammation, and insulin signaling.\n[14]\n\nEndocrine-disrupting chemicals\n\nEndocrine-disrupting chemicals, including bisphenol A (BPA), phthalates, and certain pesticides, act as \"obesogens\" by interfering with normal hormonal signaling pathways. BPA is detected in 93% of children, while phthalates are ubiquitous in the environment.\n[15]\n\nChronic low-grade inflammation\n\nAdipose tissue in obesity becomes a source of chronic inflammation through the infiltration of macrophages and the alteration of adipokine secretion. M1-polarized macrophages can comprise up to 40% of adipose tissue cells in severe obesity, secreting proinflammatory cytokines, including tumor necrosis factor-α, interleukin (IL)-6, and IL-1β.\n[16]\n\nClinical Implications of Obesity Pathophysiology\n\nA thorough understanding of obesity pathophysiology enables clinicians to set realistic weight loss goals, often targeting an initial reduction of 5% to 10% of body weight. This knowledge allows clinicians to explain the biological mechanisms underlying weight loss plateaus and weight regain, thereby helping patients maintain motivation throughout their treatment. By recognizing the complex biological underpinnings of obesity, clinicians can justify the need for long-term treatment plans and sustained maintenance strategies. This perspective also supports reducing weight bias and stigma, shifting the focus from personal blame to the medical complexity of the condition. Furthermore, understanding specific physiological mechanisms guides the selection of therapeutic interventions most likely to achieve effective and lasting results.\n\nTable\nYour patient asks, \"Why can't I keep the weight off? I lost 30 pounds last year but regained it all despite continuing my diet.\" How do you explain the biological basis for weight regain?\n\nAdipokine Dysregulation and Inflammatory Signaling\n\nAdipose tissue functions as an active endocrine organ secreting numerous bioactive molecules called adipokines that regulate energy homeostasis, inflammation, and metabolic function. In obesity, adipose tissue undergoes significant remodeling characterized by adipocyte hypertrophy, macrophage infiltration, and altered adipokine secretion profiles that shift toward a proinflammatory state. This dysregulation represents a fundamental mechanism linking obesity to its associated comorbidities, including insulin resistance, type 2 diabetes, and cardiovascular disease.\n\nThe adipokine secretion profile in obesity demonstrates a characteristic pattern of increased proinflammatory mediators and decreased anti-inflammatory factors. Proinflammatory adipokines, including tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-8 (IL-8), are elevated in obese individuals and contribute to systemic inflammation and insulin resistance by activating inflammatory signaling pathways, such as nuclear factor-κB (NF-κB) and c-Jun N-terminal kinase (JNK). Conversely, beneficial adipokines such as adiponectin, which normally enhance insulin sensitivity and exert anti-inflammatory effects, are paradoxically decreased in obesity despite increased adipose tissue mass. This imbalance creates a state of chronic low-grade inflammation that perpetuates metabolic dysfunction and increases cardiovascular risk.\n[17]\nSee\nImage.\nAdipokine Dysregulation and Inflammatory Signaling.\n\nEnergy Expenditure Components and Metabolic Regulation\n\nTotal daily energy expenditure comprises several distinct components that collectively determine metabolic rate and energy balance. Resting metabolic rate (RMR), also known as resting energy expenditure (REE), represents the most significant component, accounting for approximately 60 to 75% of total energy expenditure in sedentary individuals. This component reflects the energy required for essential physiological functions, including cellular maintenance, organ function, protein synthesis, and ion transport. The thermic effect of food (TEF), which accounts for approximately 8% to 10% of total expenditure, encompasses the energy required for digesting, absorbing, transporting, and metabolizing nutrients. Physical activity accounts for the most variable component, ranging from 15% to 30% of total expenditure and including both exercise activity thermogenesis (EAT) and non-exercise activity thermogenesis (NEAT).\n\nUnderstanding these energy expenditure components is crucial for obesity management as each responds differently to interventions and exhibits varying degrees of adaptive regulation. During caloric restriction, all components can undergo adaptive reductions that defend against weight loss, with RMR showing metabolic adaptation and NEAT demonstrating substantial decreases that contribute to weight loss plateaus. The relative contribution of each component varies significantly among individuals based on factors such as age, sex, body composition, genetics, and training status, necessitating individualized approaches to obesity treatment that account for these physiological variations.\n[18]\nSee\nImage.\nEnergy Expenditure Components and Metabolic Regulation."
  }
}